Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of the Polish National Scientific Societies, 2024 Update.

Endokrynologia Polska Pub Date : 2024-01-01 DOI:10.5603/ep.103845

Daria Handkiewicz-Junak, Marek Niedziela, Andrzej Lewiński, Artur Bosowski, Ewa Chmielik, Agnieszka Czarniecka, Marek Dedecjus, Bożenna Dembowska-Bagińska, Aneta Gawlik-Starzyk, Wojciech Górecki, Jerzy Harasymczuk, Barbara Jarząb, Jolanta Krajewska, Aleksandra Kropińska, Anna Kucharska, Paweł Kurzawa, Ewa Małecka-Tendera, Przemysław Mańkowski, Dariusz Polnik, Lech Pomorski, Andrzej Prokurat, Anna Raciborska, Renata Stawerska, Anna Taczanowska-Niemczuk, Magdalena Tarasińska

{"title":"Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of the Polish National Scientific Societies, 2024 Update.","authors":"Daria Handkiewicz-Junak, Marek Niedziela, Andrzej Lewiński, Artur Bosowski, Ewa Chmielik, Agnieszka Czarniecka, Marek Dedecjus, Bożenna Dembowska-Bagińska, Aneta Gawlik-Starzyk, Wojciech Górecki, Jerzy Harasymczuk, Barbara Jarząb, Jolanta Krajewska, Aleksandra Kropińska, Anna Kucharska, Paweł Kurzawa, Ewa Małecka-Tendera, Przemysław Mańkowski, Dariusz Polnik, Lech Pomorski, Andrzej Prokurat, Anna Raciborska, Renata Stawerska, Anna Taczanowska-Niemczuk, Magdalena Tarasińska","doi":"10.5603/ep.103845","DOIUrl":null,"url":null,"abstract":"<p><p>The rapid progress made in recent years in thyroid cancer research has necessitated the systematic updating of current clinical recommendations. This update presents the evidence-based management of differentiated thyroid carcinoma (DTC) and medullary thyroid carcinoma in children, including preoperative diagnostics, surgical management, radioiodine therapy in DTC treatment with L-thyroxine, disease monitoring, treatment of advanced disease, and finally, consequences of thyroid cancer treatment. Each recommendation is evaluated regarding its strength (Strength of Recommendation; SoR) and the quality of supporting data (QoE - Quality of Evidence).</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":"75 6","pages":"565-591"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endokrynologia Polska","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/ep.103845","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

The rapid progress made in recent years in thyroid cancer research has necessitated the systematic updating of current clinical recommendations. This update presents the evidence-based management of differentiated thyroid carcinoma (DTC) and medullary thyroid carcinoma in children, including preoperative diagnostics, surgical management, radioiodine therapy in DTC treatment with L-thyroxine, disease monitoring, treatment of advanced disease, and finally, consequences of thyroid cancer treatment. Each recommendation is evaluated regarding its strength (Strength of Recommendation; SoR) and the quality of supporting data (QoE - Quality of Evidence).

查看原文本刊更多论文

儿童分化型甲状腺癌的诊断和治疗-波兰国家科学学会指南，2024年更新。

近年来，甲状腺癌研究取得了快速进展，有必要对当前的临床建议进行系统的更新。本更新介绍了儿童分化型甲状腺癌（DTC）和甲状腺髓样癌的循证管理，包括术前诊断、手术管理、DTC治疗中使用l -甲状腺素的放射性碘治疗、疾病监测、晚期疾病的治疗以及甲状腺癌治疗的后果。每个推荐都会根据其强度进行评估(推荐强度；or)和支持数据的质量（QoE -证据质量）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Endokrynologia Polska

CiteScore

0.60

自引率

0.00%

发文量